Ajay Kirtane, TCT 2022: Ultrasound renal denervation, a tool for uncontrolled hypertension
Despite medications and lifestyle modifications for hypertension, there are still many cases of uncontrolled hypertension. Ultrasound renal denervation has shown to be a tool for reducing blood pressure. In this touchCARDIO interview, we speak with Dr Ajay Kirtane (Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, NY, USA) to discuss the challenges faced in uncontrolled hypertension and the positive effects of ultrasound renal denervation.Â
The abstract entitled ‘Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
Questions:
- What are the challenges faced by patients with uncontrolled hypertension, and what are the key steps in addressing these challenges? (0:18)
- What benefits in blood pressure control have been demonstrated, to date, using ultrasound renal denervation? (1:01)
Disclosures: Ajay Kirtane is a consultant for IMDS, has received expenses from Abbott Vascular, Boston Scientific, Chiesi, CSI, Medtronic, OpSens, Philips, ReCor Medical, Regeneron, Siemens and Zoll. Ajay Kirtane reports Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Abbott Vascular, Amgen, Biotronik, Bolt Medical, Boston Scientific, Canon, Chiesi, CSI, Magenta Medical, Medtronic, Merck, Neurotronic, Philips, ReCor Medical, Shockwave Medical and SoniVie. In addition to research grants, institutional funding includes fees paid to Columbia University and/or Cardiovascular Research Foundation for consulting and/or speaking engagements in which he controlled the content.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Hypertension here
